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The regulation of mitochondrial RNA processing and
its importance for ribosome biogenesis and energy
metabolism are not clear. We generated conditional
knockout mice of the endoribonuclease component
of the RNase P complex, MRPP3, and report that it
is essential for life and that heart and skeletal-mus-
cle-specific knockout leads to severe cardiomyopa-
thy, indicating that its activity is non-redundant.
Transcriptome-wide parallel analyses of RNA ends
(PARE) and RNA-seq enabled us to identify that
in vivo 50 tRNA cleavage precedes 30 tRNA process-
ing, and this is required for the correct biogenesis
of the mitochondrial ribosomal subunits. We identify
that mitoribosomal biogenesis proceeds co-tran-
scriptionally because large mitoribosomal proteins
can form a subcomplex on an unprocessed RNA
containing the 16S rRNA. Taken together, our data
show that RNA processing links transcription to
translation via assembly of the mitoribosome.INTRODUCTION
Themammalian mitochondrial genome is compact and relatively
small, only16 kb in size, and encodes 11mRNAs, aswell as two
rRNAs and 22 tRNAs required for translation (Figure 1A and re-
viewed in Rackham et al., 2012). Mammalian mitochondrial
mRNAs code for 13 proteins, which are all essential components
of the respiratory chain and theATPsynthase that are responsible
for energymaintenance byoxidative phosphorylation (OXPHOS).
Although the mitochondrial OXPHOS complexes are predomi-
nantly composed of polypeptides that are encoded by nuclear
genes and imported into mitochondria from the cytosol, their as-
sembly and function is dependent on the expression of the mito-
chondria-encoded polypeptides (Ha¨llberg and Larsson, 2014).
Furthermore, the mitochondrial genome is dependent on nu-1874 Cell Reports 16, 1874–1890, August 16, 2016 ª 2016 The Autho
This is an open access article under the CC BY-NC-ND license (http://clear-encoded proteins for replication, repair, transcription, and
translation (Ha¨llberg and Larsson, 2014; Rackham et al., 2012).
Consequently, the expression of both mitochondrial and nuclear
genes requires cooperative regulation to enable balanced energy
production. Nuclear gene expression is significantly correlated
with mitochondrial gene expression, reflecting close coordina-
tion between nuclear and mitochondrial genomes in relation to
the energy demands of different tissues (Mercer et al., 2011).
Mitochondrial genes coding for proteins and tRNAs are located
on both the heavy and light strands of themtDNA, which are tran-
scribed as large polycistronic transcripts covering almost the
entire lengthof each strand (Ha¨llberg andLarsson, 2014;Montoya
et al., 1981). This differs significantly from nuclear gene transcrip-
tion and requires several unique processing steps to form func-
tional RNAs. In nearly all cases, genes encoding for protein or
rRNA are interspersed by one or more tRNAs, which were pro-
posed to act as ‘‘punctuation’’ marks for processing by Attardi
and colleagues (Ojala et al., 1981). This processing involves cleav-
age at the 50 end of tRNAs by the RNase P complex (Holzmann
et al., 2008; Sanchez et al., 2011) and cleavage of the 30 ends by
the mitochondrial RNase Z (Brzezniak et al., 2011; Sanchez
et al., 2011). Processing is followed by maturation of the RNAs,
the assembly of the rRNAs into mitochondrial ribosomes, and
translation of the mRNAs using tRNAs. Although previously not
investigated in vivo, it has been proposed that regulation of the
processing of mitochondrial tRNAs might have profound effects
on mitochondrial gene expression, the assembly of the protein
synthesis machinery, and the overall level of translation, particu-
larly in mitochondrial diseases caused by mutations in regulatory
mtDNA-encodedgenessuchas tRNAsand inmitochondrialRNA-
binding proteins that regulatemitochondrial gene expression and
are nuclear encoded (Sanchez et al., 2011; Rackhamet al., 2012).
In animal mitochondria, the RNase P complex lacks the RNA
catalytic component and is composed of only three protein sub-
units, mitochondrial RNase P protein 1 (MRPP1), MRPP2, and
MRPP3 (Holzmann et al., 2008). The MRPP1 subunit of mito-
chondrial RNase P enzyme has a conserved guanine methyl-
transferase domain that modifies adenines or guanines at posi-
tion 9 of mitochondrial tRNAs in addition to its role as a subunitr(s).
creativecommons.org/licenses/by-nc-nd/4.0/).
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of RNase P (Sanchez et al., 2011; Vilardo et al., 2012). MRPP2 is
a member of the short-chain dehydrogenase superfamily, and
mutations in the gene encoding this protein cause mitochondrial
disease as a result of impaired RNA processing, further indi-
cating that it is required for RNase P activity (Vilardo and Ross-
manith, 2015; Zschocke, 2012). MRPP3 consists of a metallonu-
clease domain, which carries out the endonuclease cleavage,
and a pentatricopeptide repeat (PPR) RNA-binding domain (Li
et al., 2015; Reinhard et al., 2015). The PPR proteins represent
a large family of sequence-specific RNA-binding proteins that
play a role in organelle gene expression (Small et al., 2013). In
mammals, there are only seven PPR domain proteins, all of
which are in mitochondria and regulate the different aspects of
mitochondrial RNA metabolism from transcription (the mito-
chondrial RNA polymerase, POLRMT) (K€uhl et al., 2014), to pro-
cessing (PPR domain containing proteins 1 and 2, PTCD1 and
PTCD2, mitochondrial RNase P protein 3, MRPP3) (Holzmann
et al., 2008; Li et al., 2015; Sanchez et al., 2011; Rackham
et al., 2009; Reinhard et al., 2015; Xu et al., 2008), maturation
and stability (the leucine-rich PPR cassette protein, LRPPRC)
(Ruzzenente et al., 2012; Sasarman et al., 2010), and protein syn-
thesis (the mitochondrial ribosomal protein of the small subunit
27, MRPS27, and PTCD3) (Davies et al., 2012, 2009).
Although in vitro studies have shown that the RNase P com-
plex cleaves mitochondrial tRNAs at their 50 end (Holzmann
et al., 2008; Sanchez et al., 2011), knowledge is lacking about
the hierarchy of RNA processing and the consequences of
impaired RNA processing on mitochondrial function in vivo.
This is particularly important becausemutations in themitochon-
drial genome that preclude RNA processing at different sites
and generate unprocessed transcripts have dire consequences
for mitochondrial biogenesis and energy maintenance. Further-
more, we and others have shown that mutations in MRPP1
and MRPP2 lead to severe multi-system disorders and mito-
chondrial diseases by disruption of 50 tRNA processing (Meto-
diev et al., 2016; Zschocke, 2012), and similarly disruption of
the 30 RNA processing as a result of mutations in ELAC2 (the
mitochondrial RNaze Z enzyme) causes cardiomyopathy and
mitochondrial disease (Haack et al., 2013).
We have generated conditional Mrpp3 knockout mice and
show here that MRPP3 is required for early embryo development
and life. Heart- and skeletal-muscle-specific lossofMRPP3 leads
to a profound cardiomyopathy and a short lifespan.We show that
RNA processing by MRPP3 is required for the biogenesis of the
respiratory complexes, their activity, and mitochondrial respira-Figure 1. Full-Body Knockout of MRPP3 Causes Embryonic Lethality a
(A) Schematic representation of the gene organization in mammalian mtDNA.
(B) Schematic showing the disruption of theMrpp3 gene (also known as 1110008L
in the mouse genome by homologous recombination. The long homology arm (L
(C) Homologous recombination at the Mrpp3 locus shown by Southern blotting.
(D) Morphology of the Mrpp3+/+ and Mrpp3/ embryos at day E8.5. Scale bar,
(E) Heart weight to body weight ratio in control (L/L) and knockout mice (L/L, cre) a
cre n = 12; at 11 weeks, L/L n = 12, L/L, cre n = 12. Error bars, SEM; **p < 0.01;
(F) H&E, NADH, and COX and trichrome gomorii staining of hearts from control (
(G) Levels ofAtf4,Atf5, andChopmRNAswere determined in isolated total heart R
are expressed relative to control mice and normalized to 18S rRNA.
(H)Mrpp3 transcript levels were determined in isolated total heart RNA from contro
relative to control mice and normalized to 18S rRNA.
1876 Cell Reports 16, 1874–1890, August 16, 2016tion. Impaired RNA processing precludes the assembly of the
ribosomal subunits and thereby the mitochondrial ribosome
(mitoribosome). Interestingly, the mitoribosomal proteins are
reduced in theabsenceof amature rRNA, althougha subcomplex
of a subset of large ribosomal proteins is able to form on the un-
processed rRNA transcript. Finally, we identify all of the in vivo
RNase P cleavage sites and provide a mechanistic link for RNA
processing between transcription and protein synthesis.
RESULTS
MRPP3 Is Essential for Development, and Heart-
Specific Loss of MRPP3 Causes Cardiomyopathy
MRPP3 shares homology with the proteinaceous RNase P
(PRORP) enzymes that lack an RNA catalytic subunit and cleave
the 50 ends of tRNAs in mitochondria, chloroplasts as well as the
nucleus of plants and protists (Gobert et al., 2010; Taschner
et al., 2012). Despite having an endonuclease domain for the cat-
alytic cleavage of tRNAs, the mitochondrial MRPP3 protein in
animal mitochondria requires two additional proteins MRPP1
and MRPP2 for RNase P activity (Holzmann et al., 2008). To un-
derstand the in vivo role of MRPP3 in animal mitochondria, we
generated a conditional knockout allele of the mouse Mrpp3
gene by flanking exon 3 with loxP sites in embryonic stem (ES)
cells (Figures 1B and 1C) and subsequent transmission through
the germline to obtain heterozygous Mrpp3 +/loxP-puro animals.
These mice were crossed with transgenic mice expressing the
Flp recombinase to excise the puromycin cassette (Figure 1B),
and the resultingMrpp3+/loxP mice were mated to mice express-
ing Cre recombinase under the control of the b-actin promoter to
generate heterozygous Mrpp3 knockout mice (Mrpp3+/). Inter-
crossing the Mrpp3+/ mice produced Mrpp3+/ and Mrpp3+/+
mice in Mendelian proportions (genotyped pups n = 115,
Mrpp3+/ n = 66 and Mrpp3+/+ n = 49); however, the homozy-
gous knockout mice (Mrpp3/) were not viable. Previous ana-
lyses of essential proteins involved in mitochondrial gene
expression have observed embryonic lethality at E8.5 (Ca´mara
et al., 2011; Larsson et al., 1998; Metodiev et al., 2009, 2014;
Park et al., 2007; Ruzzenente et al., 2012); therefore, we
analyzed the embryos at this stage to identify thatMrpp3/ em-
bryos had not developed normally compared to those observed
for Mrpp3+/+ and Mrpp3+/ mice, and hence the loss of MRPP3
was embryonic lethal (Figure 1D). Based on these findings, we
conclude that MRPP3 is essential for embryo development and
survival.nd Cardiomyopathy in Heart-Specific Knockout Mice
Rik and Kiaa0391). LoxP sites flanking exon 3 of theMrpp3 gene were inserted
HA), floxed regions (FR), and short homology arm (SHA) are shown.
1 mm.
t different ages. At 4 weeks, L/L n = 8, L/L, cre n = 8; at 8 weeks, L/L n = 12, L/L,
***p < 0.001, Student’s t test.
L/L) and knockout mice (L/L, cre).
NA from control (L/L) and knockoutmice (L/L, cre) by qRT-PCR (n = 5). The data
l (L/L) and knockoutmice (L/L, cre) by qRT-PCR (n = 5). The data are expressed
Next, we crossed Mrpp3+/loxP mice with transgenic
mice expressing a Cre recombinase under the control of
muscle creatinine kinase promoter (Ckmm-cre) to produce
heart- and skeletal-muscle-specific Mrpp3 knockout mice
(Mrpp3loxP/loxP, +/Ckmm-cre). The MRPP3 mice with Ckmm-
cre-directed knockout have a short lifespan and die by 11 weeks
of cardiomyopathy, determined by the increased size of the
heart, by measuring the heart weight to body weight ratio (Fig-
ure 1E) and by histology, indicating the accumulation of necrotic
foci in the myocardium of these mice (Figure 1F). Furthermore,
we observed that the transcription factors ATF4 and ATF5, that
are elevated in cardiomyopathy as a result of mitochondrial
dysfunction (Dogan et al., 2014), are significantly increased in
the Mrpp3 knockout mice compared to their age and sex
matched controls (Mrpp3loxP/loxP), and this increase is most
apparent at 11 weeks (Figure 1G). These physiological changes
in the knockout mice are a consequence of the Mrpp3 deletion
and loss of Mrpp3 expression measured by qRT-PCR over 4,
8, and 11 weeks (Figure 1H). We confirmed that loss of Mrpp3
expression in skeletal muscle over the same time (Figure S1A)
resulted in reduced muscle fiber appearance and reduction
in complex I and complex IV staining (Figure S1B), without
any effects on ATF4 and ATF5 expression (Figure S1C), indi-
cating that cardiomyopathy is the major cause of death in these
mice.
Defects in RNA Processing Increase the Rate of
Transcription and Impair Protein Synthesis
We investigated the effects of MRPP3 loss on mitochondrial
transcription by de novo pulse and chase labeling with 32P/radio-
labeled uridine triphosphate (UTP) and identified that impaired
tRNA 50 end processing led to a significantly increased rate of
transcription relative to controls (Figure 2A). It is interesting
that the mature 12S and 16S rRNA bands that most prominently
featured in the controls are not observed in theMrpp3 knockout
mice, and instead we observe higher molecular weight unpro-
cessed transcripts in these mice (Figure S2A). Northern blotting
of these membranes confirmed that mitochondrial mRNAs,
tRNAs, and rRNAs are contained within the higher molecular
weight bands in the Mrpp3 knockout mice and that there are
no mature transcripts produced in these mice compared to con-
trols (Figure S2B). In contrast, de novo mitochondrial translation
measured using 35S-methionine and cysteine incorporation re-
vealed significant reduction in protein synthesis of all mitochond-
rially encoded proteins in theMrpp3 knockout mice compared to
controls (Figure 2B). Immunoblotting of mtDNA- and nuclear-en-
coded polypeptide components of the electron translocating
respiratory complexes revealed a significant decrease in their
levels that is most pronounced at 11 weeks in the Mrpp3
knockout mice (Figure 2C). The two subunits of the ATP syn-
thase, ATP5A and ATP8, were present at near normal levels.
Loss of MRPP3 did not affect the levels of the complex II subunit
SDHB (Figure 2C), indicating that the reduction of the nuclear-
encoded subunits of the other respiratory complexes was a
consequence of the decreased levels of the mitochondria-en-
coded respiratory polypeptides that form the same complexes.
This indicates that loss of mitochondrial tRNA 50 end processing
affects the biogenesis of the electron translocating respiratorycomplexes and is rate limiting for their formation. Furthermore,
we show that increased transcription is not sufficient to over-
come the inability to process the newly produced transcripts.
MRPP3 Is Required for Mitochondrial Respiratory
Complex Biogenesis and Function
We investigated the effects of MRPP3 loss on the abundance
and integrity of the mitochondrial respiratory complexes by
blue native (BN)-PAGE (BN-PAGE). We observed decreased
abundance of all proton translocating respiratory complexes in
theMrpp3 knockout mice, but not in the control mice (Figure 2D).
In addition, we measured the in-gel activities of complexes I and
IV and show that they are dramatically reduced in the Mrpp3
knockout mice relative to controls (Figure 2D). Loss of MRPP3
results in significant reduction of respiratory supercomplexes
as a result of their decreased biogenesis and stability (Figures
2D). The reduced levels of the respiratory complexes in the
Mrpp3 knockout mice were confirmed by immunoblotting
following BN-PAGE and confirmed that the levels of complex II
are slightly increased (Figure S2C).
Next, we determined the consequences of MRPP3 loss on
mitochondrial function by measuring the activities of respiratory
complexes in control andMrpp3 knockout mice (Figures 2E and
2F). The activities of complexes I, III, and IV were all significantly
decreased in the Mrpp3 knockout mice, consistent with their
decreased levels observed on BN-PAGE and immunoblotting
(Figures 2D and S2C). Complex II activity was slightly increased
(Figure 2E), which is typically observed when there is a general
oxidative phosphorylation (OXPHOS) defect (Duff et al., 2015).
Measurement of mitochondrial oxygen consumption showed
that there was a significant reduction in the non-phosphory-
lated, phosphorylated, and uncoupled respiration state in the
Mrpp3 knockout mice (Figure 2F). Therefore, loss of MRPP3
causes profound mitochondrial dysfunction by causing general
OXPHOS defects, further indicating that RNA processing is
essential for mitochondrial function.
TheMitochondrial RNase P Regulates the Processing of
Canonical tRNA 50 Ends
MRPP3 has been shown to cleave the 50 ends of mitochondrial
tRNAs when it is part of the RNase P complex with MRPP1
and MRPP2 in vitro (Holzmann et al., 2008; Li et al., 2015; Rein-
hard et al., 2015). We have shown that the mitochondrial RNase
P cleaves the 50 ends of mitochondrial tRNAs and can have pro-
miscuous activity toward RNAs that have tRNA-like structures at
their 50 ends in cells (Sanchez et al., 2011). However, all of these
effects have been investigated in cells grown in high glucose
where the MRPP3 levels have been knocked down and given
the high stability of the protein it is necessary to investigate the
effects of MRPP3 loss in vivo. Furthermore the hierarchy of
RNA processing has not been investigated previously; therefore,
we analyzed the effects of the MRPP3 loss on the order of cleav-
age and abundance of steady-state mitochondrial RNAs in
hearts by northern blotting over 4, 8, and 11 weeks.
MRPP3 loss leads to gradual loss of mature mRNAs such as
mt-Co1, mt-Nd1, mt-Atp8/6, and mt-Cyt b by 11 weeks and a
converse increase in the accumulation of unprocessed and pre-
cursor transcripts (Figure 3A). In contrast, the mature mt-Nd5Cell Reports 16, 1874–1890, August 16, 2016 1877
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Figure 2. Loss of MRPP3 Impairs Mito-
chondrial Biogenesis and Increases Tran-
scription
(A) In organello transcription was measured in
heart mitochondria in the presence of 32P-labeled
UTP, and the radiolabeled RNA was isolated and
resolved on a 0.9% formaldehyde gel that was
visualized by autoradiography. VDAC was used
as a loading control. The data are representative
of results obtained for 11-week-old L/L and L/L,
cre mice (n = 6) in three independent biological
experiments.
(B) Protein synthesis in heart mitochondria from
11-week-old control and knockout mice was
measured by pulse incorporation of 35S-labeled
methionine and cysteine. Equal amounts of mito-
chondrial protein (50 mg) were separated by SDS-
PAGE, immunoblotted for VDAC to show equal
loading and visualized by autoradiography.
Representative gels are shown of three indepen-
dent biological experiments.
(C) Mitochondrial proteins (25 mg) from 4-, 8-, and
11-week-old heart mitochondria from control and
knockout mice were resolved on 4%–20% SDS-
PAGE gels and immunoblotted against antibodies
to investigate the steady-state levels of nuclear
and mitochondrial-encoded proteins. ATP5A was
used as a loading control.
(D) Heart mitochondria (75 mg) treated with 1%
digitonin were separated on a 4%–30% BN-
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alized by Coomassie staining. In-gel activity stains
were used for complex I and complex IV.
(E) Respiratory complex activities were measured
spectrophotometrically and normalized to citrate
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hearts of 11-week-old control and knockout mice
(n = 6). Error bars, SEM; **p < 0.01; ***p < 0.001,
Student’s t test.
(F) Loss of the MRPP3 causes profound reduction
in mitochondrial respiration at complex I, II-III,
and IV in the KO mice compared to controls.
Non-phosphorylating (state 4), phosphorylating
(state 3), and uncoupled respiration in the pres-
ence of 0.5 mM carbonyl cyanide 3-chlor-
ophenylhydrazone (CCCP) was measured in heart
mitochondria using an Oroboros oxygen electrode
using pyruvate, glutamate and malate, or succi-
nate as a substrates in the presence of rotenone as
indicated. Error bars, SEM; **p < 0.01; ***p < 0.001,
Student’s t test.
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levels are not dramatically affected by the loss of MRPP3 (Fig-
ure 3A), which is likely a consequence of its organization within
themitochondrial genome (Figure 1A). The 30 end of tRNALeu(CUN)
is in effect the 50 end ofmt-Nd5 that is cleaved by the mitochon-
drial RNase Z or ELAC2 along with its 30 end, thereby allowing it
to be produced as a correctly processed mature mRNA. The 30
end ofmt-Nd5 is a ‘‘mirror tRNA’’ of tRNAGlu, whichmust be pro-
cessed by either ELAC2 or another endonuclease because it
seems to be unaffected by the loss of MRPP3. MRPP3 loss
also leads to lack of mature tRNAs as a consequence of their
accumulation within unprocessed transcripts (Figure 3B). The
levels of the mature mitochondrial rRNAs are significantly
decreased, whereas unprocessed transcripts accumulate in
the Mrpp3 knockout mice relative to controls (Figure 3C). It is
interesting to note that the organization of the 12S and 16S
rRNAs should allow them to be processed by the RNase Z at
the 30 ends thereby leaving them with tRNAVal and tRNALeu(UUR)
attached at their 50 ends, respectively. However, instead we
observe loss of each 12S and 16S rRNA by 11 weeks (Figure 3C)
providing the first experimental evidence that 30 tRNA process-
ing is dependent on functional 50 tRNA processing to release
the rRNAs.
We used qRT-PCR to investigate processing events across
every canonical junction in the mitochondrial transcriptome (Fig-
ure 3D) and to account for any junctions that are not processed
by the RNase P complex that was not possible to assess by
northern blotting because of the organization of the genome (Fig-
ure 1A) and the hierarchical RNA processing. There was signifi-
cant accumulation of precursors in the Mrpp3 knockout mice
compared to controls. The magnitude of changes in these pre-
cursors indicates the stabilities of their unprocessed forms as
well as the efficiency of normal processing at these junctions
(Figure 3D). For example the mt-Cyt b-tRNAPro precursor was
the most abundant and likely most stable, compared to the
mtNd4-mtNd5 and mtNd5-mtNd6 precursors that were least
abundant because of the multiple ELAC2 sites that span
mtNd4-mtNd5 and that mtNd5-mtncNd6 does not require
MRPP3 for processing (Figure 3D). Interestingly, because the
qRT-PCR examined individual junctions we were able to identify
two sites, between themt-ATP8/6 andmt-Co3 and the 50 end of
mt-Nd6, that are not cleaved by RNase P. We have shown pre-
viously that the 50 end ofmt-Nd6 is produced by cleavage at the
30 end of tRNAGlu by the RNase Z, ELAC2 (Sanchez et al., 2011),
and FASTKD5 affects the processing of the mt-ATP8/6 and
mt-Co3 precursor, commonly known as RNA14 (Antonicka and
Shoubridge, 2015). We identified a similar increase in junction
accumulation in skeletal muscle (Figure S2D), identifying that
mitochondrial dysfunction (Figures S1A–S1C) was a result of
impaired RNA processing due to loss of MRPP3 in this tissue.Figure 3. Loss of MRPP3 Causes Impaired RNA Processing
(A–C) The abundance of mature mitochondrial mRNAs (A), tRNAs (B), and rRNA
analyzed by northern blotting. 18S rRNA was used as a loading control. The data
and three independent biological experiments.
(D) The canonical mitochondrial RNA junctions were measured in total heart RNA
18S rRNA. Error bars, SEM; **p < 0.01; ***p < 0.001, Student’s t test.
(E) Frequency distribution of PARE reads from heart mitochondrial RNA from th
centered on reads that align 15 nt away from either side of all annotated 50 ends
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We used parallel analyses of RNA ends (PARE) (German et al.,
2009; Mercer et al., 2011; Rackham and Filipovska, 2014a) to
investigate the distribution of 50 ends across the entire mitochon-
drial transcriptome from three control and three knockout mice,
respectively, and identify the 50 canonical, and any previously
unknown sites, that are processed byMRPP3 (Figure 3E) and ac-
count for cleavage sites that are a result of other processing en-
zymes (Figure 4A; Table S1). PARE captures 20-nt tags from
the 50 ends of 50-monophosphorylated RNAs and the normalized
read count at the 50 terminal positions accumulate at canonical
and abundant processing sites to form identifiable peaks, whose
relative change between control and knockout mice reveals sites
of impaired processing upon the loss of MRPP3 (i.e., Figure 4B).
We found a dramatic reduction in reads mapping to the anno-
tated 50 ends of transcripts derived from both the heavy and light
strands of the mitochondrial genome (Figure 3E), confirming that
MRPP3 is critical for their processing. We present a transcrip-
tome-wide map of 50 end processing sites (Figures 4A and
S3A) that identified and confirmed the canonical cleavage sites
detected by qRT-PCR (Figure 3D). Furthermore PARE identified
that 50 end cleavage precedes 30 processing by the mitochon-
drial RNase Z enzyme ELAC2 because we observe a dramatic
decrease in processing at the 50 ends of mt-mRNAs that border
the 30 ends of the adjacent tRNA, which should be substrates for
ELAC2. For example, there is a marked decrease in cleavage at
the 50 end of 16S rRNA, which borders the 30 end of mt-tRNAVal
(Figure 4B); we found the same consistent reduction in the pro-
cessing of the 50 end of mt-Nd1 mRNA, which borders the 30
end of mt-tRNALeu(UUR) (Figure 4C) and a reduction in the 50
end of mt-Nd2 mRNA, which borders the 30 end of mt-tRNAMet
(Figure S3B). We confirmed our PARE findings further by tran-
scriptome-wide RNA sequencing (RNA-seq) of three control
and three knockout mice (Figure 4A) where, unlike for PARE,
these libraries captured longer reads across the entire mitochon-
drial transcriptome and excluded short RNAs, such as tRNAs.
Consequently, this technique captures tRNAs that are part of
unprocessed transcripts and by analyzing reads that span pro-
cessed regions in the mitochondrial transcriptome we quantified
regions that are increased in the MRPP3 knockout mice where
processing is impaired. Therefore, regions between processing
sites where processing is impaired should have an increased
abundance of reads in RNA-seq datasets but reduced process-
ing events, peaks, in PARE datasets. In our RNA-seq datasets,
we found an enrichment of reads across junctions that span
tRNA regions between the mRNA and rRNA genes, indicating
an increase in precursor RNAs. In support of this, we observe
a concomitant reduction in mature mtRNAs as a result of the
accumulation of the polycistronic precursor mtRNAs on northerns (C) in hearts from 4-, 8-, and 11-week-old control and knockout mice were
are representative of results obtained from at least eight mice from each strain
from control (L/L) and knockout (L/L, cre) mice by qRT-PCR and normalized to
ree control (L/L; blue) and three knockout (L/L, cre; red) mice. Windows are
of mitochondrial tRNAs from the heavy and light chain.
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blots (Figures 3A–3C). The accumulation of precursor transcripts
shown by RNA-seq correlates well with the decrease or loss of 50
and 30 ends found with the PARE data as well as the northern
blots indicating that there is a hierarchy of mtRNA processing
where 50 end processing is the initial step in vivo.
Although we found a decrease in 30 end processing, we
observed at least one instance where ELAC2 activity was not
affected or increased by the lack of 50 processing, such as at
the 30 end of tRNALys, which borders the 50 end ofmt-Atp8/6 (Fig-
ure 4D). This effect might be due to the increased stability or
abundance of these RNAs in the absence of RNase P processing
as indicated by the increased levels of this precursor transcript in
our qRT-PCR data (Figure 3D). Interestingly, we identified two
sites where the ELAC2 activity is increased in the knockout
mice in a region containing multiple tRNAs encoded by both
the heavy and light strand (Figure S3C). We find that the 30
ends of both heavy-strand-encoded tRNAIle and tRNATrp are
increased (Figure S3C), even though the 30 ends of their respec-
tive light-strand-encoded tRNAGln and tRNAAla are decreased,
which may be due to altered structures of these regions when
flankingRNAsequences are not removedor heavy strand ‘‘mirror
tRNA’’ structures that are recognized by ELAC2 and cleaved.We
observe an increased ‘‘mirror’’ tRNATyr cleavage on the heavy
strand in the knockout mice (Figure S4A), the same site that
was recently identified three nucleotides upstream of the anno-
tated 50 of the mt-Co1 mRNA (Okui et al., 2016), suggesting
that this site is cleaved independently of MRPP3.
We identified a site between the mt-Atp8/6 and mt-Co3
mRNAs that is not covered in our PARE datasets (Figure 4D).
The absence of this 50 end suggests that this sitemay not contain
a 50 phosphate as it is required for PARE and it may be processed
by an entirely different mechanism. In addition, in RNA-seq
coverage we find a dramatic change at the junction between
mt-Atp8/6 and mt-Co3 in the knockout mice, suggesting that
ELAC2 or another endonuclease such as FASTKD5 (Antonicka
and Shoubridge, 2015) may be able to preferentially cleave
around this site in the absence of MRPP3.
In the PARE data from the knockout mice, we observed an
increased number of free 50 ends across the entire lengths of
transcripts, which was indicative of degradation, most likely of
the precursor transcripts that accumulate as a result of impairedFigure 4. Transcriptome-wide Analyses of 50 tRNA Cleavage Sites by P
(A) A completemap of changes in 50 end abundance (1, 5; log2 fold change[KOmean
three control (L/L) and three knockout (L/L, cre) mice, on heavy (1, 2) and light (4, 5
genome is displayed in the central track (3), with the nucleotide position in base
green, tRNAs in blue, and the non-coding region (NCR) in gray.
(B) Genome browser view of the 50 end abundance from three control (L/L) and thr
in mean 50 end abundance (middle; log2 fold change[KOmean/Ctrlmean]), and mean
cleavage sites ofmt-tRNAVal byMRPP3 and the downstream effect on the 30 end o
(for 50 ends) and green (for 30 ends) boxes.
(C) Genome browser view of the 50 end abundance from three control (L/L) and thr
in mean 50 end abundance (middle; log2[KOmean/Ctrlmean]), and mean RNA-seq
mt-tRNALeu(UUR) byMRPP3 and the downstream effect on the 30 end of themt-Nd
ends) and green (for 30 ends) boxes.
(D) Genome browser view of the 50 end abundance from three control (L/L) and thr
in mean 50 end abundance (middle; log2 fold change[KOmean/Ctrlmean]), and mea
non-canonical region between mt-Atp8/6 and mt-Co3 and the 50 cleavage sites
mRNA in the absence of MRPP3. Regions of interests are shown in gray (for 50 e
1882 Cell Reports 16, 1874–1890, August 16, 2016processing and increased transcription, which produces a high
load of unprocessed RNAs within mitochondria (Figure 4A).
This was also apparent in the significant reduction of mature
mtRNAs in the RNA-seq datasets (Figure 4A) as well as those
found by northern blotting (Figures 3A–3C). We investigated
the specificity of mtRNA degradation digitally by searching for
motifs around the cleavage sites that are enriched in the absence
of MRPP3 and correlating it to the abundance of each nucleotide
in the heavy and light strand of the mouse mitochondrial tran-
scriptome (Figure S4B).We conclude that the degradation is car-
ried out by an endonuclease that lacks sequence specificity.
Mitochondrial RNA Processing Is Required for the
Assembly of the Mitoribosome and the Stability of
Ribosomal Proteins
To investigate the changes in gene expression as a result of
MRPP3 loss, we carried out transcriptome-wide RNA-seq and
identified the most significant effects on heart and mitochondrial
function (Figure 5A). We observed a significant decrease of car-
diac markers such as cardiac actin and myosins as well as the
ryanodine receptor 2 (Figure 5A; Table S2), consistent with the
development of cardiomyopathy (Figures 1D and 1F). Tran-
scripts encoding mitochondrial proteins, particularly those en-
coding the electron transport chain polypeptides, were most
changed in response to MRPP3 loss and consequent mitochon-
drial dysfunction (Figure 5A; Table S2). Also, transcripts involved
in translation were significantly affected, and those involved in
mitochondrial translation were reduced, whereas transcripts
involved in cytosolic translation were increased, likely as a way
to stimulate mitochondrial biogenesis and compensate for
dysfunctional energy metabolism (Figure 5B). We investigated
the effects of MRPP3 loss on the mRNAs encoding mitochon-
drial ribosomal proteins and identified that their levels were
largely reduced (Figure 5B), consistent with the loss of mitochon-
drial translation (Figure 2B).
Mitochondrial gene expression is predominantly regulated
at the post-transcriptional level by RNA-binding proteins (Liu
et al., 2013). Therefore, to investigate the consequences of
impaired tRNA 50 end processing over 4, 8, and 11 weeks and
validate our RNA-seq data, we analyzed the effects of MRPP3
loss on nuclear-encoded mitochondrial RNA-binding proteinsARE and RNA-Seq
/Ctrlmean]) and RNA-seq coverage (2, 4; log2 fold change[KOmean/Ctrlmean]) from
) strands. Increases are shown in red and decreases in blue. The mitochondrial
pairs displayed across the exterior; rRNAs are displayed in orange, mRNAs in
ee knockout (L/L, cre) mice (top; mean normalized count), and relative changes
RNA-seq coverage (bottom; log2 fold change[KOmean/Ctrlmean]) showing the 5
0
f the 12S rRNA in the absence ofMRPP3. Regions of interests are shown in gray
ee knockout (L/L, cre) mice (top; mean normalized count), and relative changes
coverage (bottom; log2[KOmean/Ctrlmean]) showing the 5
0 cleavage sites of
1mRNA in the absence of MRPP3. Regions of interests are shown in gray (for 50
ee knockout (L/L, cre) mice (top; mean normalized count), and relative changes
n RNA-seq coverage (bottom; log2 fold change[KOmean/Ctrlmean]) showing the
of mt-tRNALys by MRPP3 and the lack of effect on the 30 end of the mt-Atp8/6
nds) and green (for 30 ends) boxes.
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Figure 5. Impaired RNA Processing Causes
an Imbalance in Nuclear-Encoded Mito-
chondrial Proteins
Transcriptome-wide RNA-seq was carried out on
total heart RNA from three control (L/L) and three
knockout (L/L, cre) mice, and differential expres-
sion analyses were performed.
(A and B) Significant differences (p < 0.05) in
positively and negatively correlated transcripts
relative to controls are based on specific gene
ontologies are shown for cardiac markers and
mitochondrial genes (A) and for oxidative phos-
phorylation, the translation machinery, and mitor-
ibosomal and RNA-binding proteins (B).
(C) The levels of nuclear-encoded mitochondrial
RNA-binding proteins were measured by immu-
noblotting in heart mitochondria from 4-, 8-, and
11-week-old control (L/L) and knockout (L/L, cre)
mice.
(D) Mitochondrial ribosomal protein abundance
was measured by immunoblotting in heart mito-
chondria from 4-, 8-, and 11-week-old L/L and L/L,
cre mice.by immunoblotting. We found that the increased rate of tran-
scription in the Mrpp3 knockout mice (Figure 2A) was a conse-
quence of increased POLRMT levels as a retrograde response
of nuclear gene expression to impaired mitochondrial tRNA pro-
cessing (Figure 5C). Similarly, we observed increased levels of
the two mitochondrial transcription factors, TFAM and TFB2M,
in Mrpp3 knockout mice at 8 and 11 weeks of age (Figure 5C).
The levels of the other two RNase P proteins, MRPP1 and
MRPP2, were also increased, as well as those of ELAC2 (Fig-
ure 5C), likely to compensate for the loss of MRPP3. Interest-
ingly, the LRPPRC protein, required for the stability and transla-
tion of mt-mRNAs, is also increased at weeks 8 and 11, possibly
as a consequence of the low levels of mature mRNAs. The levels
of POLRMT are consistently increased from 4 to 11 weeks in
contrast to the other mitochondrial RNA-binding proteins that
show an initial decrease in their levels at week 4 in the Mrpp3
knockout mice but increase their levels relative to controls by
weeks 8 and 11 (Figure 5C). This suggests that the initialCell Repcompensatory response to impaired
RNA processing is to increase the rate
of transcription, which has also been
observed upon knockout of mitochon-
drial RNA-binding proteins that affect
the stability of the ribosome such as
TFB1M, MTERF3, and MTERF4 (Ca´mara
et al., 2011; Metodiev et al., 2009; Park
et al., 2007). This is in contrast to other
proteins that regulate mitochondrial
gene expression, such as LRPPRC,
where the rate of transcription is not
affected (Ruzzenente et al., 2012).
Since mitochondrial protein synthesis
was significantly reduced in the Mrpp3
knockout mice, we investigated the ef-
fects of MRPP3 loss on the steady-statelevels of mitoribosomal proteins (Figure 5D). We found that the
levels of some ribosomal proteins were increased in the Mrpp3
knockout mice, such as MRPS34 and MRPL12, whereas some
were decreased such as MRPS35 and MRPL37 (Figure 5D),
consistent with the differential expression and enrichment ana-
lyses of the mRNAs encoding mitoribosomal proteins found in
our RNA-seq data (Figure 5A; Table S2). These findings indicate
that impaired tRNA processing affects mitoribosome stability, as
we have observed before in cells (Sanchez et al., 2011).
To investigate the effects of impaired tRNA processing on the
assembly and stability of the ribosome, we resolved the mitori-
bosomal subunits and assembled ribosomes on 10%–30% su-
crose gradients and examined them by immunoblotting against
markers of the small and large ribosomal subunits (Figure 6A).
We identify that loss of MRPP3 and hence tRNA 50 end process-
ing impairs 55S monosome formation (Figure 6A). Furthermore,
we observed a shift of the small and large ribosomal subunit
proteins toward the less dense sucrose fraction in the Mrpp3orts 16, 1874–1890, August 16, 2016 1883
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Figure 6. Mitochondrial Ribosome Assem-
bly Is Impaired as a Consequence of
Impaired RNA Processing
(A) A continuous 10%–30% sucrose gradient was
used to determine the distribution of the small and
large ribosomal subunit and the monosome in the
control and knockout mice. Mitochondrial ribo-
somal protein markers of the small (MRPS35) and
large (MRPL37, MRPL44, MRPL11, and MRPL12)
ribosomal subunits were detected by immuno-
blotting with specific antibodies. The input (10% of
the total lysate) was used as a positive control. The
data are representative of results from at least
three independent biological experiments.
(B and C) The distribution of the mt-Co1 mRNA,
12S and 16S rRNAs (B), and 12S-16S rRNA junc-
tions (C) in sucrose gradients were analyzed
by qRT-PCR. The data are expressed as percent-
age of total RNA abundance and are representa-
tive of results from four independent biological
experiments.
1884 Cell Reports 16, 1874–1890, August 16, 2016
knockout mice compared to controls (Figure 6A). The shift in
small ribosomal subunit proteins was dramatic, indicating that
the assembly of these proteins on unprocessed 12S rRNA is
not possible or at least severely impaired. In contrast, the large
ribosomal subunit proteins were shifted but still migrated in a
large molecular weight complex, suggesting that a partial ribo-
somal subcomplex is formed. It is possible that an unprocessed
rRNA transcript may be sufficient to stimulate the assembly of
the early assembling ribosomal proteins that form a subcomplex
but are unable to complete the assembly of the mature subunits.
Interestingly, the MRPL37 and MRPL11 proteins, whose abun-
dance was decreased like most mitoribosomal proteins exam-
ined, were only found in this subcomplex, while MRPL12, whose
abundance was increased in the knockout (Figure 5D), and
MRPL44, were found both in the subcomplex and in a rRNA
free state in the less dense fractions. This indicates that some
ribosomal proteins are stable when unassembled, while others
are not. Whether free mitoribosomal proteins might contribute
to mitochondrial dysfunction is not known.
Next, we investigated the distribution of mitochondrial tran-
scripts within the ribosomal fractions by qRT-PCR of each frac-
tion (Figure 6B) to determine the distribution of the unprocessed
transcripts within the sucrose gradient in the control mice. The
distribution of the 12S and 16S rRNA follows a similar pattern
as that observed by immunoblotting against markers of the small
and large ribosomal subunits, respectively (Figure 6B). However,
we observe a redistribution of these transcripts in the Mrpp3
knockout mice to less dense fractions of the sucrose gradient
(Figure 6B) that co-migrate with the unprocessed polycistronic
transcripts that contain both the 12S and 16S rRNAs (Figure 6C).
Similarly, we observe that the mt-Co1 mRNA is present in the
pool of free mt-mRNAs in the top fractions as well as with the ri-
bosomal fractions in the control mice; however, it is re-distrib-
uted only to the earlier fractions in the Mrpp3 knockout mice
because there are no correctly assembled mitoribosome
subunits to recruit mRNAs (Figure 6B). We find that the mt-
tRNALeu(UUR) is not present in its mature form, but instead it is
also part of the large unprocessed transcript found in the
Mrpp3 knockout mice (Figure S4C). We do not observe a poly-
cistronic transcript in the control mice, indicating that the unpro-
cessed transcript that co-migrates with the large subcomplex
detected in the immunoblots Mrpp3 knockout mice (Figure 6A)
is composed of ribosomal proteins that assemble on the unpro-
cessed transcript containing the 12S and 16S rRNA. RNase A
treatment of mitochondrial lysates before sucrose gradient sep-
aration (Figure 6C) identified that the precursor transcript is lost
upon RNase treatment, as this transcript is not protected it is
likely that it is not bound by a complete complement of mitoribo-
somal proteins.
To identify the ribosomal proteins that are present in the sub-
complex found in fraction 10 on the precursor transcript, we car-
ried out proteomic analyses on fractions that contained the small
(fraction 8) and large subunit (fraction 10) or the subcomplex
(fraction 8 and 10) and the monosome (fractions 12 and 13)
from both the control and Mrpp3 knockout mice (Figure 7). We
confirmed that the monosome is not formed in the Mrpp3
knockout mice, compared to the control mice where we find
the highest abundance of both small and large ribosomal pro-teins in the monosome fractions (Figure 7). In control mice, the
distribution of the small and large subunits is consistent with their
migration in the gradient, where the small and large ribosomal
subunit proteins are found in the fractions containing the mono-
some (fractions 12 and 13). In theMrpp3 knockout mice, we find
enrichment of large ribosomal proteins in fraction 10 indicating
that these proteins assemble on the unprocessed transcript to
form the subcomplex observed by immunoblotting (Figure 6A).
Furthermore, as we detected an enrichment of the majority of
large subunit proteins in fraction 10, this complexmust be stalled
close to the end of the large subunit assembly pathway. Taken
together, we have shown that RNA processing is rate limiting
for the assembly of the mitochondrial ribosomal subunits and
the 55S monosome.
DISCUSSION
The compact organization of the mitochondrial genome in ani-
mals has eliminated the necessity for RNA splicing of non-coding
inter- and intragenic sequences. Instead, the tRNA genes sepa-
rate themRNAs and rRNAs in away that permits the tRNA endor-
ibonucleases to cleave them from the large polycistronic tran-
scripts produced by the mitochondrial RNA polymerase and
releaseall individualmtRNAs (Ojala et al., 1981). Although twoen-
zymes involved in 50 and 30 tRNA processing have been identified
as the RNase P complex and ELAC2, the importance of RNA pro-
cessing (Brzezniak et al., 2011; Holzmann et al., 2008; Sanchez
et al., 2011) and the consequences of its loss have not been
investigated in vivo. Here, we investigated the loss of tRNA 50
end processing upon conditional heart- and muscle-specific
knockout of the Mrpp3 gene, encoding the endonuclease
component of the mitochondrial RNase P complex. We show
that RNA processing is essential for early embryo development,
and its knockout in the heart and skeletal muscle leads to very
early onset cardiomyopathy that causes the mice to die by
11 weeks. Clearly, RNA processing is essential for life since
severely impaired biogenesis of mitochondrial ribosomes and
OXPHOS complexes leads to mitochondrial dysfunction. Our
data further corroborate in vitro findings (Holzmann et al., 2008)
and demonstrate that there are no alternative RNase P enzymes
to compensate for the loss of the 50 endonuclease activity of
MRPP3. Impaired RNA processing has been shown recently
due to mutation of theMRPP1,MRPP2, and ELAC2 genes in pa-
tients with mitochondrial disease and cardiomyopathy (Haack
et al., 2013; Metodiev et al., 2016; Vilardo and Rossmanith,
2015). Interestingly, in all three cases although RNA processing
was shown to be impaired there was not a significant effect on
the mature mtRNA levels, which is particularly curious. These ef-
fects may be a consequence of growth of patient cells in vitro in
highly anaerobic conditions or the tissue-specific response of fi-
broblasts compared to heart and muscle cells and tissues, both
of which do not impose the same bioenergetic requirements as
in vivo systems. The requirement for RNA processing for life re-
sults in the observation of very mild hypomorphic mutations in
these genes,masking thedeleterious effects onRNAmetabolism
and making these effects difficult to detect in these patients.
Loss ofMRPP3 in vivo abolishes tRNA 50 end processing, trap-
ping the individual mtRNAs in precursor transcripts and therebyCell Reports 16, 1874–1890, August 16, 2016 1885
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Figure 7. Differential Distribution of Mitochondrial
Ribosomal Proteins upon Loss of MRPP3
Mass spectrometry was used to analyze the distribution of
the mitochondrial ribosomal proteins in sucrose gradient
fractions that contained the small (fraction 8) and large ri-
bosomal subunit (fraction 10) and the monosome (fractions
12 and 13) in the control (L/L) mice and compared to the
same fractions in theMrpp3 knockout mice (L/L, cre), both at
11 weeks. The analyses were performed on fractions from
three separate biological experiments from three control and
three knockout mice (n = 3). The results of the ANOVA
analysis were adjusted for multiple testing using the Benja-
mini and Hochberg procedure. Only proteins with adjusted
p value of less than 0.01 (1% FDR) were termed significant
and marked with asterisk (*).
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leads to profound reduction of most mature mtRNAs. The posi-
tion of specific tRNAs or mRNAs within or adjacent to clusters of
tRNA genes suggested that perhaps the activity of ELAC2 could
rescue some of these transcripts by cleaving neighboring 30 ends
as we observed for mt-Nd5. However, this was not the case
for the rRNAs where we found large unprocessed transcripts
that precluded the correct assembly of the small and large ribo-
somal subunits. Although the levels of ELAC2 were moderately
increased when MRPP3 was lost, they were not sufficient to
rescue the processing of specific 30 end sites that are also 50
ends of flanking RNAs. We conclude that tRNA 50 end process-
ing is required as the initial step of RNA processing preceding 30
tRNA cleavage. It is not clear why 50 processing is required in
most cases for 30 processing to proceed, perhaps because the
MRPP3 enzyme is more agnostic to structure, while RNase Z
activity is inhibited by long 50 leaders both for tRNA processing
(Nashimoto et al., 1999) and cleavage of tRNA-like RNAs (Wilusz
et al., 2008).
Interestingly, we identify two different sites that are not
changed by the loss of MRPP3, one at the 50 end of mt-Cyt b
and the other at the 50 end of mt-Co3. A gene trap mutant of
the Ptcd2 gene in mice has shown that the 50 end of mt-Cyt b
is not processed in the absence of PTCD2, suggesting that
this protein may have a role in its cleavage (Xu et al., 2008).
PTCD2 belongs to the PPR family of mitochondrial RNA-binding
proteins in animals; like MRPP3, however besides its PPRs it
lacks a canonical endoribonuclease domain, suggesting that
there may be a new fold within its tertiary structure that can carry
out this activity or that it recruits an unidentified endoribonu-
clease that can cleave this site. PPR proteins across different
kingdoms can interact and recruit other RNA-binding proteins
for their activity, such as the RNase P complex with the
MRPP1 and MRPP2 (Holzmann et al., 2008; Li et al., 2015; Rein-
hard et al., 2015) and the LRPPRC/SLIRP complex (Lagouge
et al., 2015; Ruzzenente et al., 2012; Sasarman et al., 2010) in
animals or PPR proteins and MORF proteins in plants (Takenaka
et al., 2012).
We annotated all the known MRPP3 cleavage sites in our
work, accounting for all in vivo processing events carried out
by the RNase P complex. Furthermore, we observed a dramatic
increase in 50 endswithin internal regions ofmtRNAs upon loss of
MRPP3 and 50 end processing. These are likely products of RNA
degradation, and the general loss of these transcripts at their 30
ends suggests that degradation is in the 30 to 50 direction. It re-
mains to be determined which mitochondrial endonuclease is
responsible for this removal of unprocessed RNAs, and a recent
report suggests that LACTB2 may act as a mitochondrial endo-
nuclease (Levy et al., 2016).
Mitochondrial gene expression relies solely on the post-tran-
scriptional import of nuclear-encoded RNA-binding proteins
and other protein factors (Ha¨llberg and Larsson, 2014; Rackham
et al., 2012). Knockout of mitochondrial RNA-binding proteins
has been shown to increase the levels of other nuclear-encoded
factors in an effort to compensate for the changes in gene
expression (Ca´mara et al., 2011; Metodiev et al., 2009, 2014;
Park et al., 2007; Ruzzenente et al., 2012). We observed similar
increases in RNA-binding protein levels upon MRPP3 loss, but
most strikingly we observed a dramatic increase in POLRMTlevels and mitochondrial transcription. Furthermore, the varying
effects on the mitochondrial ribosomal proteins suggested that
the expression and stability of these proteins is differentially
regulated. Nevertheless the dramatic changes that result from
impaired tRNA 50 end cleavage on transcription and protein
synthesis indicate that RNA processing couples these two
processes.
The cleavage of the 50 ends of tRNAs is essential for ribosome
assembly, which, in turn, is clearly a process that links transcrip-
tion and translation. In addition, it indicates that it is the initial
step of RNA processing, since ELAC2 and any other endoribonu-
cleases cannot overcome the lack of 50 processing. The small
subunit is dependent on the mature 12S rRNA for assembly
because its assembly is severely impaired in the Mrpp3
knockout mice, and consequently the 55S ribosome cannot
form. This may indicate that correctly processed 50 and 30 ends
are required to initiate the early assembly events in small subunit
formation. Thismirrors bacterial ribosome assembly where the 50
and 30 ends of the 16S and 23S rRNAs must juxtapose for effi-
cient ribosome biogenesis (Young and Steitz, 1978). However,
it is interesting to note that a large subunit subcomplex can
form using an unprocessed 16S rRNA and contains a number
of large ribosomal subunit proteins, suggesting that some ribo-
somal proteins can assemble without the requirement for 16S
rRNA processing. This is highly unusual, although the mitochon-
drial ribosome is unique in that it contains a much higher protein
content compared to rRNA, as well as additional ribosomal pro-
teins that are not found in cytoplasmic or prokaryotic ribosomes
(Rackham and Filipovska, 2014b; Suzuki et al., 2001a, 2001b),
suggesting that some of these could have unusual characteris-
tics that may allow them to initiate binding or their stabilization by
association with the unprocessed RNA. The MRPP3 knockout
mouse has been useful to identify the ribosomal proteins
involved in the initial assembly of the large mitochondrial ribo-
somal subunit, as the rRNAs become available following tran-
scription. Taken together, we have shown that RNA processing
is rate limiting for the assembly of the mitochondrial ribosomal
subunits that occurs co-transcriptionally.
Here, we have shown the dire consequences of impairedmito-
chondrial RNA processing and that this is an essential step in
mitochondrial RNA metabolism required for biogenesis and
energy production. The next goal is to elucidate the precise
mode of ribosome assembly that is clearly dependent on the
generation of mature rRNAs. This will undoubtedly be a long
and interesting journey with additional complexities as this tiny
but mighty transcriptome has revealed so far.EXPERIMENTAL PROCEDURES
Animals and Housing
Mrpp3 transgenic mice on a C57BL/6N background were generated by Ta-
conic. The puromycin cassette was removed by mating Mrpp3+/loxP-neo mice
with transgenic mice ubiquitously expressing Flp recombinase. The resulting
Mrpp3+/loxP mice were mated with mice ubiquitously expressing Cre recombi-
nase to generate heterozygous knockout Mrpp3+/ mice that were bred with
each other to identify that the homozygous loss of Mrpp3 was embryonic le-
thal. Heart- and skeletal muscle-specific knockout mice were generated by
crossing Mrpp3loxP/loxP mice with transgenic mice expressing Cre under
the control of the muscle creatinine kinase promoter (Ckmm-cre). DoubleCell Reports 16, 1874–1890, August 16, 2016 1887
heterozygous mice (Mrpp3loxP/+, +/Ckmm-cre) were mated withMrpp3loxP/loxP
mice to generate heart-specific knockout (Mrpp3loxP/loxP, +/Ckmm-cre) and
control mice (Mrpp3loxP/loxP). Mice were housed in standard cages (45 cm 3
29 cm 3 12 cm) under a 12-hr light/dark schedule (lights on 7 a.m. to 7
p.m.) in controlled environmental conditions of 22 ± 2C and 50 + 10% relative
humidity and fed a normal chowdiet (Rat &MouseChow, Specialty Foods) and
water were provided ad libitum. The study was approved by the Animal Ethics
Committee of the University of Western Australia (UWA) and performed in
accordance with Principles of Laboratory Care (National Health and Medical
Research Council [NHMRC] Australian code for the care and use of animals
for scientific purposes, 8th Edition 2013) and Federation for Laboratory Animal
Science Associations (FELASA), Germany.
Mitochondrial Isolation
Mitochondria were isolated from homogenized hearts and isolated by differen-
tial centrifugation as described previously (Lagouge et al., 2015; Mourier et al.,
2014), with some modifications as described in the Supplemental Information.
Sucrose Gradient Fractionation
Sucrose gradient fractionation was carried out as described previously
(Lagouge et al., 2015; Metodiev et al., 2009; Ruzzenente et al., 2012) with
some modifications as described in the Supplemental Information.
Immunoblotting
Specific proteins were detected using rabbit polyclonal antibodies against
POLRMT, LRPPRC, TFB2M, TFAM, ATP8 (produced in-house, diluted
1:1,000), MRPP1, MRPP2, ELAC2, MRPL44, MRPL37 (1:1,000), MRPL12
(1:500), MRPS35 (1:1,000), MRPS16 (Proteintech), and MRPS34 (Sigma,
diluted 1:1,000) and mouse monoclonal antibodies against b-actin, voltage-
dependent anion channel (VDAC), NDUFA9, complex II, complex III, COXI,
COXII, COXIV, and complex V subunit a (Abcam, diluted 1:1,000), in Odyssey
Blocking Buffer (Li-COR Biosciences). IR Dye 800CW goat anti-rabbit immu-
noglobulin G (IgG) or IRDye 680LT goat anti-mouse igg (Li-COR Biosciences)
secondary antibodies were used, and the immunoblots were visualized using
an Odyssey Infrared Imaging System (Li-COR Biosciences).
Mass Spectrometric Data Analyses
Protein and peptide identification was performed using Peaks (Ma et al.,
2003) v.7.5. Raw data were searched against the canonical and isoform se-
quences of the mouse reference proteome (proteome ID UP000000589,
June 2014) from UniProt. For data analysis, cysteine carbamidomethylation
was set as ‘‘fixed modification’’ and methionine oxidation and protein N-ter-
minal acetylation as ‘‘variable modification.’’ The digestion parameters were
set to ‘‘Trypsin’’ allowing for cleavage after lysine and arginine when not fol-
lowed by proline with up to two missed cleavages. Database searching was
performed using mass error tolerance of 10 ppm (parent) and 0.4 Da (frag-
ment). Up to two variable modifications per peptide were allowed, and false
discovery rate (FDR) estimation was enabled. Upon database searching,
the peptide identification FDR was set at 1%; default criteria were used for
protein identification. Peaks database search results were exported and
used further for peptide and protein quantification. Label-free quantification
was performed using Skyline (v.3.5.0.9319) (MacLean et al., 2010) using
the MS1 filtering approach (Schilling et al., 2012). For the analyses, the
peptides.pep.xml Peaks export file and a custom fasta database containing
the sequences of all identified mitoribosomal proteins were imported into
Skyline. For the fasta database import, ‘‘Trypsin [KR j P]’’ was set as a prote-
ase allowing for up to two missed cleavages. Regarding the full-scan settings,
the precursor charges were set to two, three, and four. MS1 filtering was per-
formed using three peaks (M, M+1 and M+2), ‘‘Orbitrap’’ was selected as a
mass analyzer with resolving power of 60,000 at 200 m/z. Only scans within
5 min of MS/MS IDs were considered. After data import, the extracted ion
chromatograms of all peptides mapping to the selected mitoribosomal pro-
teins were manually inspected. In some cases, the peak integration was
adjusted manually. When no distinct peak was present, data integration
was performed over a retention time region, which is in agreement with the
replicated analysis of the same and the remaining fractions. Upon manual
evaluation, the peptide intensity data were exported and assembled into1888 Cell Reports 16, 1874–1890, August 16, 2016protein intensity data using an in-house script. Similarly to other label-
free approaches (Wisniewski and Rakus, 2014), protein intensities in all four
fractions were transformed into proportions of the total protein intensity in
all four fractions, in order to derive the relative distribution of a protein in
the gradient fractions. The proportion values in each fraction were used to
perform a two-way ANOVA analysis using two factors, ‘‘Genotype,’’ ‘‘Frac-
tion,’’ and their interaction. The ANOVA analysis was performed in R (R Devel-
opment Core Team, 2013, http://www.r-project.org/), using the analysis of
variance (aov) function. The results of the ANOVA analysis were adjusted
for multiple testing using the Benjamini and Hochberg procedure (Benjamini
and Hochberg, 1995). Only proteins with adjusted p value of less than 0.01
(1% FDR) were termed significant.
RNA Isolation, Northern Blotting, and qRT-PCR
RNA was isolated from total hearts or heart mitochondria using the miRNeasy
Mini kit (QIAGEN) incorporating an on-column RNase-free DNase digestion to
remove all DNA. RNA (5 mg) was resolved on 1.2% agarose formaldehyde gels
and then transferred to 0.45 mm Hybond-N+ nitrocellulose membrane (GE
Healthcare Life Sciences) and hybridized with biotinylated oligonucleotide
probes specific tomousemitochondrial mRNAs, rRNAs, and tRNAs (Rackham
et al., 2009). Hybridizations were carried out overnight at 50C in 53 saline
sodium citrate (SSC), 20 mM Na2HPO4, 7% SDS, and 100 mg 3 ml
–1 heparin,
followed by washing. The signal was detected using either streptavidin-linked
horseradish peroxidase or streptavidin-linked infrared-labeled antibody
(diluted 1:2,000 in 33 SSC, 5% SDS, 25 mM Na2HPO4 [pH 7.5]) by enhanced
chemiluminescence (GE Healthcare Life Sciences) or using an Odyssey
Infrared Imaging System (Li-COR Biosciences), respectively.
cDNA was prepared using the QuantiTect Reverse Transcription Kit
(QIAGEN) and used as a template in the subsequent PCR that was performed
using a Corbett Rotorgene 6000 using SensiMix SYBR mix (Bioline) and
normalized to 18S rRNA.
RNA-Seq, PARE, and Alignments
RNA sequencing was performed on total RNA or mitochondrial RNA from
three control and three Mrpp3 knockout mice using the Illumina HiSeq plat-
form, according to the Illumina Tru-Seq protocol or PARE protocol (German
et al., 2009; Mercer et al., 2011; Rackham and Filipovska, 2014a). Library prep-
aration, sequencing, and bioinformatics analyses are described in detail in the
Supplemental Information.
Transcription and Translation Assays
In organello transcription and translation assays were carried out in isolated
heart mitochondria as described before (Lagouge et al., 2015).
Blue Native PAGE
BN-PAGE was carried out using isolated mitochondria from hearts as
described previously (Mourier et al., 2014). BN-PAGE gels were analyzed by
in-gel activity assays or by transferring to polyvinylidene fluoride (PVDF) and
immunoblotting against the respiratory complexes.
Respiratory Chain Function and Complex Activity
Themitochondrial oxygen consumption flux was measured with an Oxygraph-
2k (Oroboros Instruments), as previously described (Mourier et al., 2014;
Lagouge et al., 2015).
Histology
Mouse hearts were fixed with 10% neutral buffered formalin for 24 hr and
stored in PBS or 70% ethanol. Tissues were embedded in paraffin, sectioned
using a microtome, and transferred to positively charged slides. Slides were
heated for 2 hr at 60C and treated with xylene, xylene and ethanol (1:1),
and decreasing concentrations of ethanol (100%, 95%, 80%, 60%) before
they were washed in distilled H2O (dH2O). The H&E staining was performed
as described before (Richman et al., 2015). Skeletal muscle was frozen
in OCT, and the tissue was sectioned and stained for complex I and IV activity
using NADH and cytochrome c oxidase as substrates. Coverslips were
attached using DPXmounting media (Scharlau) and images were acquired us-
ing a Nikon Ti Eclipse inverted microscope using a Nikon 203 objective.
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